[go: up one dir, main page]

PE34397A1 - Inhibicion de la fotodescomposicion de 2-oxindoles 3-sustituidos - Google Patents

Inhibicion de la fotodescomposicion de 2-oxindoles 3-sustituidos

Info

Publication number
PE34397A1
PE34397A1 PE1996000275A PE00027596A PE34397A1 PE 34397 A1 PE34397 A1 PE 34397A1 PE 1996000275 A PE1996000275 A PE 1996000275A PE 00027596 A PE00027596 A PE 00027596A PE 34397 A1 PE34397 A1 PE 34397A1
Authority
PE
Peru
Prior art keywords
substituted
photodescomposition
oxydoles
inhibition
red
Prior art date
Application number
PE1996000275A
Other languages
English (en)
Inventor
Jr Willard C Newlin
Sharon M Laughlin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PE34397A1 publication Critical patent/PE34397A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polymerisation Methods In General (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

CARACTERIZADO POR LA INTRODUCCION DE UN MEDIO FOTOABSORBENTE (CAPAZ DE ABSORBER LAS LONGITUDES DE ONDA DE LA LUZ, MENORES DE 600 nm.), QUE COMPRENDE UN RECUBRIMIENTO DEL COMPRIMIDO O CAPSULA QUE CONTIENE LA 2-OXINDOL 1-CARBOXAMIDA 3-SUSTITUIDA DE FORMULA (I), DONDE: X ES H, Cl O F; Y ES H O Cl; R ES BENCILO O TIENILO OPCIONALMENTE SUSTITUIDO CON Cl O F. ESTE RECUBRIMIENTO COMPRENDE SUFICIENTE COLORANTE Y LACA AMARILLO N�6, ROJO N�3 Y ROJO N�40 O UNICAMENTE AMARILLO N�6, COMO PARA REDUCIR SIGNIFICATIVAMENTE LA FORMACION DE PRODUCTOS DE DEGRADACION INDUCIDOS POR LA LUZ
PE1996000275A 1995-04-24 1996-04-22 Inhibicion de la fotodescomposicion de 2-oxindoles 3-sustituidos PE34397A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1995/000287 WO1996033701A1 (en) 1995-04-24 1995-04-24 Inhibiting photodecomposition of 3-substituted-2-oxindoles

Publications (1)

Publication Number Publication Date
PE34397A1 true PE34397A1 (es) 1997-09-29

Family

ID=36997502

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1996000275A PE34397A1 (es) 1995-04-24 1996-04-22 Inhibicion de la fotodescomposicion de 2-oxindoles 3-sustituidos

Country Status (30)

Country Link
EP (1) EP0827399A1 (es)
JP (1) JPH10506635A (es)
KR (1) KR100189585B1 (es)
CN (1) CN1053667C (es)
AP (1) AP607A (es)
AR (1) AR002728A1 (es)
AU (1) AU692378B2 (es)
BG (1) BG100531A (es)
BR (1) BR9602024A (es)
CO (1) CO4700418A1 (es)
FI (1) FI973988A0 (es)
HR (1) HRP960194A2 (es)
HU (1) HU216544B (es)
IL (1) IL117969A0 (es)
IS (1) IS4339A (es)
MA (1) MA23848A1 (es)
NO (1) NO961622L (es)
NZ (1) NZ286432A (es)
OA (1) OA10286A (es)
PE (1) PE34397A1 (es)
RO (1) RO113305B1 (es)
RU (1) RU2109510C1 (es)
SG (1) SG64924A1 (es)
SI (1) SI9600133A (es)
SK (1) SK51296A3 (es)
TR (1) TR199600300A2 (es)
UA (1) UA42739C2 (es)
WO (1) WO1996033701A1 (es)
YU (1) YU25096A (es)
ZA (1) ZA963210B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019132959A1 (en) 2017-12-29 2019-07-04 Kraft Foods Group Brands Llc Improved oxidative stability of oil-in-water emulsions using natural stabilizers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT59592A (en) * 1990-07-20 1992-06-29 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of solid medical products
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Also Published As

Publication number Publication date
NZ286432A (en) 1998-05-27
UA42739C2 (uk) 2001-11-15
SK51296A3 (en) 1997-04-09
CN1053667C (zh) 2000-06-21
HUP9601057A2 (en) 1997-04-28
AP607A (en) 1997-08-27
IL117969A0 (en) 1996-08-04
KR960037656A (ko) 1996-11-19
AU692378B2 (en) 1998-06-04
JPH10506635A (ja) 1998-06-30
FI973988A (fi) 1997-10-17
CN1139110A (zh) 1997-01-01
FI973988A0 (fi) 1997-10-17
SG64924A1 (en) 1999-05-25
AP9600787A0 (en) 1996-04-30
HU216544B (hu) 1999-07-28
NO961622D0 (no) 1996-04-23
HU9601057D0 (en) 1996-06-28
WO1996033701A1 (en) 1996-10-31
IS4339A (is) 1996-10-25
NO961622L (no) 1996-10-25
SI9600133A (en) 1996-10-31
AU5085196A (en) 1996-11-07
TR199600300A2 (tr) 1996-11-21
KR100189585B1 (ko) 1999-06-01
AR002728A1 (es) 1998-04-29
BR9602024A (pt) 1998-10-06
CO4700418A1 (es) 1998-12-29
YU25096A (sh) 1998-08-14
BG100531A (en) 1997-06-30
EP0827399A1 (en) 1998-03-11
RU2109510C1 (ru) 1998-04-27
ZA963210B (en) 1997-10-23
HRP960194A2 (en) 1998-02-28
MA23848A1 (fr) 1996-12-31
RO113305B1 (ro) 1998-06-30
HUP9601057A3 (en) 1997-05-28
OA10286A (en) 1997-09-19

Similar Documents

Publication Publication Date Title
MX9302906A (es) Derivados de mercaptoacetilamida novedosos utiles como inhibidores de la encefalinasa.
AR004087A1 (es) Derivado del acido fenilacetico, procedimientos y productos intermedios para su obtencion y las composiciones que los contienen
NO302573B1 (no) Nye merkaptodiazepinderivater som er anvendbare som inhibitorer av enkefalinase og ACE
BR9305907A (pt) Uso de derivados de substituída para tratamento de esclerose múltipla
AR038430A2 (es) Derivados de parahercuamida b
ES2196054T3 (es) Derivados de acido fenilacetico, procedimiento y productos intermedios para su obtencion y agentes que contienen los mismos.
ES2170147T3 (es) Metodo para mejorar la eficacia de los productos quimicos agricolas.
ES2099522T3 (es) Procedimiento para teñir medios organicos.
UY27338A1 (es) Nuevos derivados de ácido sulfónico
MX9207137A (es) Nuevos oligodesoxirribonucleotidos, que tienen una actividad anti-isquemica, y metodos para su preparacion
MX9304399A (es) Proceso novedoso para preparar [[2-bromoetil)-amino]metil]-2-nitro-1h-imidazol-1-etanol quiral y compuestos relacionados.
ES2187738T3 (es) Derivados de flavonas, su procedimiento de preparacion y los compuestos farmaceuticos que las contienen.
ES2190471T3 (es) Procedimiento para producir derivados de guanidina, intermedios de dichos compuestos y su produccion.
BR8108346A (pt) Processo para preparacao enzimatica de acido l-2-amino-4-metil-fosfinobutirico
ES2078507T3 (es) Medicinas y derivados de sulfonanilida.
NO950683L (no) Nye 2-substituterte indan-2-merkaptoacetylamidtrisykliske derivater som er anvendbare som inhibitorer av enkefalinase
ES480160A1 (es) Procedimiento de sintesis de mercaptanos.
PE34397A1 (es) Inhibicion de la fotodescomposicion de 2-oxindoles 3-sustituidos
DK0734380T3 (da) 4-Benzoylisoxazoler samt deres anvendelse som herbicider
ES2117132T3 (es) Sales de desferrioxamina-b y su uso como queladores de hierro eficaces por via oral.
ES2176463T3 (es) Procedimiento para producir derivados de 1-halo-3-amino-4fenil-2-butanol opticamente activos.
CO4890846A1 (es) Pirroles sustituidos
ES2086442T3 (es) Derivados de fluoroetilcamptotecina.
SE9200502D0 (sv) Novel antioxidants
MX9307048A (es) Derivados de piridazinoquinazolona, y composicion farmaceutica que los contiene.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed